These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


486 related items for PubMed ID: 10757339

  • 1. Hormonal pathology of the endometrium.
    Deligdisch L.
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F.
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    Duffy SR, Taylor L.
    Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
    Samsioe G.
    Int J Fertil Menopausal Stud; 1994 Dec; 39 Suppl 2():84-92. PubMed ID: 7874191
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
    Kennedy MM, Baigrie CF, Manek S.
    Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P.
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [Abstract] [Full Text] [Related]

  • 14. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I.
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [Abstract] [Full Text] [Related]

  • 15. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
    Filho AM, Barbosa IC, Maia H, Genes CC, Coutinho EM.
    Gynecol Endocrinol; 2007 Sep; 23(9):511-7. PubMed ID: 17943546
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M, Odmark IS, Risberg B, Karlsson MG, Pavlenko T, Bäckström T.
    Maturitas; 2004 Oct 15; 49(2):114-23. PubMed ID: 15474755
    [Abstract] [Full Text] [Related]

  • 17. Histopathology of functional and neoplastic changes in cervix and endometrium.
    Dallenbach-Hellweg G.
    Verh Dtsch Ges Pathol; 1997 Oct 15; 81():240-4. PubMed ID: 9474876
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP, Zettler CG, Pessini SA, Ayub AV, de Almeida SB, da Silveira GP.
    Menopause; 2009 Oct 15; 16(2):293-300. PubMed ID: 19034048
    [Abstract] [Full Text] [Related]

  • 19. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
    Williams AR, Critchley HO, Osei J, Ingamells S, Cameron IT, Han C, Chwalisz K.
    Hum Reprod; 2007 Jun 15; 22(6):1696-704. PubMed ID: 17339234
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
    Gul A, Ugur M, Iskender C, Zulfikaroglu E, Ozaksit G.
    Arch Gynecol Obstet; 2010 Mar 15; 281(3):479-83. PubMed ID: 19506890
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.